Siga Technologies (SIGA) Competitors $6.80 +0.03 (+0.37%) As of 10:21 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. IRON, BLTE, CNTA, HRMY, ADPT, SRPT, TARS, IMCR, ARQT, and SPRYShould you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include Disc Medicine (IRON), Belite Bio (BLTE), Centessa Pharmaceuticals (CNTA), Harmony Biosciences (HRMY), Adaptive Biotechnologies (ADPT), Sarepta Therapeutics (SRPT), Tarsus Pharmaceuticals (TARS), Immunocore (IMCR), Arcutis Biotherapeutics (ARQT), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical products" industry. Siga Technologies vs. Its Competitors Disc Medicine Belite Bio Centessa Pharmaceuticals Harmony Biosciences Adaptive Biotechnologies Sarepta Therapeutics Tarsus Pharmaceuticals Immunocore Arcutis Biotherapeutics ARS Pharmaceuticals Disc Medicine (NASDAQ:IRON) and Siga Technologies (NASDAQ:SIGA) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership. Does the media favor IRON or SIGA? In the previous week, Disc Medicine had 4 more articles in the media than Siga Technologies. MarketBeat recorded 7 mentions for Disc Medicine and 3 mentions for Siga Technologies. Disc Medicine's average media sentiment score of 0.75 beat Siga Technologies' score of 0.67 indicating that Disc Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Disc Medicine 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Siga Technologies 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of IRON or SIGA? 83.7% of Disc Medicine shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 4.2% of Disc Medicine shares are owned by company insiders. Comparatively, 2.0% of Siga Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, IRON or SIGA? Disc Medicine has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Is IRON or SIGA more profitable? Siga Technologies has a net margin of 40.30% compared to Disc Medicine's net margin of 0.00%. Siga Technologies' return on equity of 25.21% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -22.61% -21.07% Siga Technologies 40.30%25.21%22.05% Which has higher earnings and valuation, IRON or SIGA? Siga Technologies has higher revenue and earnings than Disc Medicine. Disc Medicine is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$109.36M-$3.92-14.84Siga Technologies$120.33M4.04$59.21M$0.6710.16 Do analysts recommend IRON or SIGA? Disc Medicine presently has a consensus target price of $96.70, suggesting a potential upside of 66.27%. Given Disc Medicine's stronger consensus rating and higher probable upside, research analysts plainly believe Disc Medicine is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryDisc Medicine and Siga Technologies tied by winning 8 of the 16 factors compared between the two stocks. Get Siga Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSiga TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$486.87M$2.45B$5.52B$9.35BDividend YieldN/A1.79%4.25%4.09%P/E Ratio10.179.2227.9519.83Price / Sales4.04761.91438.79106.18Price / Cash8.01160.6835.5357.53Price / Book2.254.718.255.72Net Income$59.21M$30.99M$3.23B$257.51M7 Day Performance-1.38%0.47%-0.13%0.59%1 Month Performance8.02%9.59%7.21%10.74%1 Year Performance-24.47%-3.76%27.45%15.87% Siga Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASiga Technologies1.9841 of 5 stars$6.81+0.4%N/A-26.9%$486.87M$120.33M10.1740IRONDisc Medicine3.2355 of 5 stars$53.38-2.5%$96.70+81.2%+19.7%$1.90BN/A-13.6230Insider TradeBLTEBelite Bio1.9919 of 5 stars$58.63-1.4%$96.67+64.9%+27.8%$1.89BN/A-43.1110CNTACentessa Pharmaceuticals3.1949 of 5 stars$13.62-3.2%$27.89+104.8%+57.6%$1.88B$6.85M-7.52200HRMYHarmony Biosciences4.8399 of 5 stars$32.24+0.2%$53.63+66.3%+1.4%$1.85B$714.73M12.31200Positive NewsADPTAdaptive Biotechnologies2.6988 of 5 stars$11.74-0.5%$10.57-10.0%+143.4%$1.79B$178.96M-12.23790SRPTSarepta Therapeutics4.7364 of 5 stars$17.32-5.0%$60.88+251.5%-87.7%$1.79B$1.90B-6.441,372Trending NewsAnalyst ForecastGap UpTARSTarsus Pharmaceuticals1.7819 of 5 stars$39.93-3.0%$66.67+67.0%+45.9%$1.73B$182.95M-14.6350News CoveragePositive NewsAnalyst RevisionIMCRImmunocore1.318 of 5 stars$32.41-1.8%$58.89+81.7%-13.9%$1.66B$310.20M-75.37320ARQTArcutis Biotherapeutics1.2713 of 5 stars$13.39-3.1%$18.80+40.4%+44.6%$1.65B$196.54M-12.88150Insider TradeSPRYARS Pharmaceuticals2.8408 of 5 stars$17.09+3.5%$31.00+81.4%+57.6%$1.62B$89.15M-106.8190 Related Companies and Tools Related Companies Disc Medicine Alternatives Belite Bio Alternatives Centessa Pharmaceuticals Alternatives Harmony Biosciences Alternatives Adaptive Biotechnologies Alternatives Sarepta Therapeutics Alternatives Tarsus Pharmaceuticals Alternatives Immunocore Alternatives Arcutis Biotherapeutics Alternatives ARS Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siga Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Siga Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.